Quickly and precisely characterize mega-mass molecules
With advanced size-exclusion chromatography (SEC) and charge detection mass spectrometry (CDMS)
The characterization of megadalton-sized biologics is vital for cell and gene therapy development and testing. However, analyzing these complex molecules can be challenging.
Learn how Lexeo Therapeutics combined SEC with multi-angle light scattering (MALS) and protoype CDMS technology to gain deeper molecular insights with speed and precision. Watch our recently published seminar featuring case studies on various biologics, including Cominarty™ (COVID-19 vaccines, mRNA), Spikevax™ (COVID-19 vaccines, mRNA), mRNA drug substances, lentiviral vectors, and AAV purity investigations from a novel Sf9-baculovirus process.